DTIL
Precision Biosciences Inc
Precision Biosciences Inc insider trading
Insiders at Precision Biosciences Inc have been buying its stock on the open market. The largest purchase in the last 30 days was Germano Geno J (Director) buying $16.4K of DTIL, filed Sep 29, 2026. Every open-market purchase and sale its officers, directors and 10% owners filed in that time is listed below, each linked to the original Form 4.
- Bought on the open market
- $23.5K
- Sold
- —
- Insiders
- 2
- Latest trade
- Sep 25, 2026
From SEC filings · last 30 days
Recent DTIL insider transactions
SEC Form 4 data, Q3 2024 to Q2 2026
DTIL insider trading by quarter
Between Jul 01, 2024 and Jun 30, 2026, 8 insiders traded DTIL on the open market: 15 purchases worth $210.4K and 20 sales worth $830.3K, 19 of the sales pre-scheduled under a 10b5-1 plan. In the last four quarters alone: 5 purchases ($54K) and 12 sales ($529.3K), by 7 insiders.
| Quarter | Bought | Sold | Insiders |
|---|---|---|---|
| Q2 2026 | — | — | |
| Q1 2026 | — | −$431.3K8 sales · all on a plan | |
| Q4 2025 | +$33.7K3 buys | −$34.9K3 sales · all on a plan | |
| Q3 2025 | +$20.3K2 buys | −$63.2K1 sale · all on a plan | |
| Q2 2025 | +$28.1K2 buys | — | |
| Q1 2025 | +$47.1K3 buys | −$271.5K6 sales · all on a plan | |
| Q4 2024 | +$81.3K5 buys | −$29.5K2 sales · 1 on a plan | |
| Q3 2024 | — | — |
- Largest purchase
- +$21.1K of DTIL by Buehler Kevin (Director) on Mar 26, 2025.
- Largest sale
- −$172K of DTIL by Amoroso Michael (President and CEO · Director) on Jan 21, 2025, under a 10b5-1 plan.
Open-market transactions through Jun 30, 2026most recent first
Amoroso Michael10b5-1
President and CEO · Director
−$78.9K
Feb 18, 2026
20,559 sh · $3.84
Kelly John Alexander10b5-1
Chief Financial Officer
−$31.3K
Feb 18, 2026
8,149 sh · $3.84
Scimeca Dario10b5-1
General Counsel and Secretary
−$18.9K
Feb 18, 2026
4,925 sh · $3.84
Smith J. Jefferson10b5-1
Chief Research Officer
−$18.9K
Feb 18, 2026
4,925 sh · $3.84
Amoroso Michael10b5-1
President and CEO · Director
−$145.1K
Jan 22, 2026
34,799 sh · $4.17
Kelly John Alexander10b5-1
Chief Financial Officer
−$61.3K
Jan 21, 2026
15,213 sh · $4.03
Smith J. Jefferson10b5-1
Chief Research Officer
−$41.1K
Jan 21, 2026
10,200 sh · $4.03
Scimeca Dario10b5-1
General Counsel and Secretary
−$35.7K
Jan 21, 2026
8,854 sh · $4.03
Germano Geno J
Director
+$14.2K
Dec 16, 2025
3,000 sh · $4.72
Frankel Stanley
Director
+$12.7K
Dec 16, 2025
2,700 sh · $4.70
Brown Melinda
Director
+$6.9K
Dec 15, 2025
1,381 sh · $4.97
Amoroso Michael10b5-1
President and CEO · Director
−$22.1K
Nov 03, 2025
3,409 sh · $6.49
Kelly John Alexander10b5-1
Chief Financial Officer
−$8.5K
Nov 03, 2025
1,303 sh · $6.49
Scimeca Dario10b5-1
General Counsel and Secretary
−$4.3K
Nov 03, 2025
665 sh · $6.49
Frankel Stanley
Director
+$13.4K
Sep 26, 2025
2,700 sh · $4.97
| Date | Insider | Shares | Price | Value |
|---|---|---|---|---|
| Feb 18, 2026 | Amoroso Michael10b5-1President and CEO · Director | 20,559 | $3.84 | −$78.9K |
| Feb 18, 2026 | Kelly John Alexander10b5-1Chief Financial Officer | 8,149 | $3.84 | −$31.3K |
| Feb 18, 2026 | Scimeca Dario10b5-1General Counsel and Secretary | 4,925 | $3.84 | −$18.9K |
| Feb 18, 2026 | Smith J. Jefferson10b5-1Chief Research Officer | 4,925 | $3.84 | −$18.9K |
| Jan 22, 2026 | Amoroso Michael10b5-1President and CEO · Director | 34,799 | $4.17 | −$145.1K |
| Jan 21, 2026 | Kelly John Alexander10b5-1Chief Financial Officer | 15,213 | $4.03 | −$61.3K |
| Jan 21, 2026 | Smith J. Jefferson10b5-1Chief Research Officer | 10,200 | $4.03 | −$41.1K |
| Jan 21, 2026 | Scimeca Dario10b5-1General Counsel and Secretary | 8,854 | $4.03 | −$35.7K |
| Dec 16, 2025 | Germano Geno JDirector | 3,000 | $4.72 | +$14.2K |
| Dec 16, 2025 | Frankel StanleyDirector | 2,700 | $4.70 | +$12.7K |
| Dec 15, 2025 | Brown MelindaDirector | 1,381 | $4.97 | +$6.9K |
| Nov 03, 2025 | Amoroso Michael10b5-1President and CEO · Director | 3,409 | $6.49 | −$22.1K |
| Nov 03, 2025 | Kelly John Alexander10b5-1Chief Financial Officer | 1,303 | $6.49 | −$8.5K |
| Nov 03, 2025 | Scimeca Dario10b5-1General Counsel and Secretary | 665 | $6.49 | −$4.3K |
| Sep 26, 2025 | Frankel StanleyDirector | 2,700 | $4.97 | +$13.4K |
From SEC's quarterly Form 3, 4 and 5 data sets: code P purchases and code S sales of common stock, by the date the trade happened. Where a fund and the people who control it each report the same block, it is counted once. Trades made in the last days of Q2 2026 but filed after it closed arrive with SEC's next quarterly release.
Don't check DTIL — let it ping you
Watch every insider filing the minute it clears the SEC
The live dashboard reads every Form 4 as it lands and puts it in plain English — open-market buys, cluster buys where several insiders move at once, and the sales executives chose to make rather than scheduled. Free to open; Pro adds alerts, watchlists and each buyer's track record.
Precision Biosciences Inc is outside the 777 companies InsiderPulse scans continuously. This page is built from the filings on the live tape and stays up while its insiders are buying. Monitoring, not advice.
Other companies insiders are buying now
Questions
- Are DTIL insiders buying or selling?
- Between Sep 25, 2026 and Sep 25, 2026, 2 Precision Biosciences Inc insiders made 2 open-market purchases worth $23.5K and no sales, a net purchase of $23.5K.
- How much DTIL stock have insiders bought and sold in the last two years?
- Between Jul 01, 2024 and Jun 30, 2026, 8 Precision Biosciences Inc insiders made 15 open-market purchases worth $210.4K and 20 sales worth $830.3K. 19 of the sales were pre-scheduled under a Rule 10b5-1 plan. In the four quarters to Jun 30, 2026: 5 purchases ($54K) and 12 sales ($529.3K). The largest purchase was Buehler Kevin buying $21.1K on Mar 26, 2025. The largest sale was Amoroso Michael selling $172K on Jan 21, 2025.
- What was the largest recent DTIL insider trade?
- Germano Geno J (Director) bought $16.4K of DTIL stock on Sep 25, 2026 at about $6.28 a share.
- When did an insider last buy DTIL shares?
- The most recent open-market purchase on file is Germano Geno J (Director) buying $16.4K on Sep 25, 2026.
- Where does DTIL insider trading data come from?
- From the Form 4 filings Precision Biosciences Inc's officers, directors and 10% owners must send the SEC within two business days of a trade. Each row on this page links to its original filing on SEC EDGAR. Share grants and option exercises are kept apart from open-market purchases and sales, because only the latter cost the insider their own money.
Get the free Insider Brief
Each weekday evening: the day's biggest open-market insider buys, cluster formations and 10b5-1 plan breaks — in plain English, with grants and routine vesting stripped out. Honest about what the data can and cannot say.